Security key
65343E108
NextCure, Inc. - Common Stock, par value $0.001 per share (NXTC)
CUSIP: 65343E108
Q1 2025 13F Holders as of 31 Mar 2025
- Security type / class
- Equity / Common Stock, par value $0.001 per share
- Total 13F shares
- 15,365,612
- Total 13F value
- $7,377,835
- Share change
- -1,103,035
- SEC-reported price per share
- $0.48
- Number of holders
- 38
- Value change
- -$659,368
- Number of buys
- 9
- Number of sells
- 17
- Shares outstanding
- 3,602,511
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2025
Institutions
38
Top holders
10
NXTC full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
NextCure, Inc. SEC filings
NextCure, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 65343E108
Recent filing periods:
Ownership snapshot
Top reported holders of NXTC - NextCure, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
CITIGROUP INC
Disclosed value leader
Sofinnova Investments, Inc.
Comparable rows
15/15
Latest evidence
31 Dec 2024
13F
13D/G
Lead comparable stake: 4.3%
13D/G row: CITIGROUP INC
Showing 1-6 of 15 holder rows.
Quick read
CITIGROUP INC leads the comparable SEC ownership view at 4.3%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens CITIGROUP INC's linked filing trail.
Comparable ownership
Top 5
CITIGROUP INC
4.3%
Sofinnova Investments, Inc.
74%
Affinity Asset Advisors, LLC
64%
PFIZER INC
40%
ORBIMED ADVISORS LLC
32%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| CITIGROUP INC |
13F
13D/G
Company · Citigroup Global Markets Inc.
|
4.3%
from 13D/G
|
$1,070,950
1,389,040 shares
|
— | 31 Dec 2024 |
| Sofinnova Investments, Inc. |
13F
Company
|
74%
|
$2,060,001
2,671,856 shares
|
— | 31 Dec 2024 |
| Affinity Asset Advisors, LLC |
13F
Company
|
64%
|
$1,775,303
2,302,598 shares
|
— | 31 Dec 2024 |
| PFIZER INC |
13F
Company
|
40%
|
$1,891,763
1,458,550 shares
|
— | 31 Dec 2024 |
| ORBIMED ADVISORS LLC |
13F
Company
|
32%
|
$879,865
1,141,200 shares
|
— | 31 Dec 2024 |
| VANGUARD GROUP INC |
13F
Company
|
27%
|
$761,227
987,324 shares
|
— | 31 Dec 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
38
Shares
15,365,612
Rows available
38
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2025 vs Q3 2025 Across Filers
Q3 2025 holders
1
Q1 2025 holders
38
Holder diff
37
| Investor | Q3 2025 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q3 2025 value | Q1 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend